Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.029
Neutral
RSI(14)
44.336
Neutral
STOCH(KDJ)(9,3,3)
44.509
Sell
ATR(14)
0.036
High Vlolatility
CCI(14)
11.462
Neutral
Williams %R
62.548
Sell
TRIX(12,20)
-1.432
Sell
StochRSI(14)
0.000
Sell
Foxo Technologies Inc
FOXOView Detailed Chart
0.153USD
-0.003-2.11%
Market hours （ET）Quotes delayed by 15 min
52.34KMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.11%
5 Days
+21.35%
1 Month
-12.63%
6 Months
-93.45%
Year to Date
-94.75%
1 Year
-92.47%
View Detailed Chart
Agency Rating
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Moving Average
Indicators
Value
Direction
MA5
0.193
Sell
MA10
0.159
Sell
MA20
0.153
Buy
MA50
0.246
Sell
MA100
0.626
Sell
MA200
1.893
Sell
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Ticker SymbolFOXO
CompanyFoxo Technologies Inc
CEOMr. Seamus Lagan
Websitehttp://delwinds.com/
Related Instruments
+1.90%
-0.67%
+1.14%
+0.59%
+1.40%
+4.51%
+2.03%
+0.54%
+1.86%
+1.44%
+1.45%
-0.48%
+1.50%
+0.64%
+0.57%
+1.64%
-1.48%
+0.21%
+1.66%
+3.08%
